Analysis of the effects of anti-vascular endothelial growth factor drugs on the anterior chamber

Analysis of the effects of anti-vascular endothelial growth factor drugs on the anterior chamber - Analysis of the effects of anti-VEGF drugs on the anterior chamber

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000047339

Enrollment

200

Registered

2022-03-31

Start date

2022-03-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

age-related macular degeneration, diabetic macular edema, neovascular glaucoma, myopia choroidal neovascularization

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients 20 years of age or older who receive or have received anti-VEGF injections

Exclusion criteria

Exclusion criteria: Cases with concomitant inflammatory diseases such as uveitis Cases in which treatment of unknown details has been performed by other hospitals. Cases in which anterior chamber fluid cannot be safely collected

Design outcomes

Primary

Measure	Time frame
Cytokines and proteins in the atrial chamber.	—

Countries

Japan

Contacts

Public ContactHideyuki Shimizu

Nagoya University Graduate School of Medicine Department of Ophthalmology

h.shimizu@med.nagoya-u.ac.jp052-744-2277

Outcome results